Smallcap
a guarunteed short?stocks are recovering. $tick is on its way to continuation with gains in indices. this top gainer explosive parabolic up move for small healthcare is following a bear trend. im willing to bet on continued decay from outside on any move but continued parabolic velocity up with bull 4hr momo. literally every other scenario is a 88% short.
Small Cap Growth (VBK) - Time to consider?The VBK small cap growth ETF is showing 305 price target on Stockcharts.com P&F, which would be 32% above Friday 2/3 close.
On the monthly Chart (not shown) VBK has posted a .618 retrace from 3/20 the low to the 11/21 high; .382 resistance is the next level on the monthly is 236.68.
On the daily chart (not shown), we have a 21/50 EMA daily crossover, but the 50 day EMA is still well below the 200 day EMA. The money flow index on the daily has been tailing off since 1/17 while riding an over bought RSI(9) since 1/17.
The weekly chart (shown above) shows VBK entering into Ichimoku cloud resistance, and a weekly resistance at a Gann confluence at 238.63. The latest up leg from 10.10 looks extended (blue Point D is near 1.61). The positive is that the VBK has soundly rejected the downward regression channel from 2022 high to low.
Small caps have in general less pricing power than the large caps(unless they hold a special niche). Passing on price increases to compensate for higher input costs can be more difficult. Easing inflation will benefit small caps, but tight labor market does not.
I do not see a 305 target on VBK anytime in the near future. I also do not see (unless there is a Swan event) lower lows. I do see sideways action inside the red cloud for the near future. Small cap growth is not for me unless I find one of those niche situations with superb financials.
Russell 2000 Index - EXPLAINED - What, Why, Where, How?Small cap stocks, Penny stocks and pink sheets are the high adrenaline stocks investors play games in.
They are generally the cheaper, highly volatile, some are illiquid and can fluctuate 50% - 1,000% a day.
From the Wolf of Wallstreet glamorizing the potential returns for investors to your every day salesman broker trying to sell you the next winner.
But what is the Russell 2000 Index and what should we know about it?
I’m going to sum it up a bit of information about how it works and important facts you need to know
Enjoy!
WHAT IS IT?
The Russell 2000 Index (listed in 1984) is a stock market index that tracks the performance of small-cap publicly traded companies in the United States.
It is named after the Russell Investment Group, which operates the index.
The share price can vary significantly, as it is made up of a diverse range of small-cap publicly traded companies.
MARKET CAP
Small-cap stocks are generally ones with a market capitalization of between:
$50 million and $2 billion.
CRITERIA TO LIST STOCKS
There are a few criteria that needs to be met to qualify for the inclusion in the Russell 2000 Index:
• The company must be a publicly traded U.S. company.
• It must market capitalization of at least $50 million.
• Must be ranked in the bottom 2,000 of the Russell 3000 Index, based on market capitalization.
• Must meet certain liquidity requirements, including having a minimum average daily trading volume of at least 250 shares over the previous six months.
• Must have a minimum of one year of trading history.
WHAT IT CONSISTS OF
The index is made up of the smallest 2,000 publicly traded companies in the Russell 3000 Index, which represents approximately 98% of the total market capitalization of all publicly traded companies in the United States.
HOW IT OPERATES
The index is reconstituted annually, with new companies added and removed based on their market capitalization and other factors.
VOLATILITY & LIQUIDITY
The Russell 2000 Index has a high level of volatility (greater price swings) and low liquidity (ease of flow of orders) compared to other large cap stocks.
DANGERS WITH THE INDEX
Currency risk: When the US dollar drops the index can follow
Diversification: There is no sector for the stocks. When the index drops the stocks follow.
Liquidity: You might find difficulties finding buyers or sellers to ease in or out of your positions.
Volatility: The jumpiness in the market is highly erratic.
Lack of analyst analysis: You’ll hardly see news coverage via the media which means, you could be left in the dark with what is going on in the companies.
Liquidation risk: You have a higher chance at being in a company that is about to be liquidated due to financial issues, no growth, manipulation and cooking the books.
Economic issues: When global economies collapse, stocks drop with it. Small cap stocks are no exceptions. This can affect the investment prospects
.
WELCORP (WELSPUN CORP LIMITED) - SMALL CAP 📊 Script: WELCORP (WELSPUN CORP LIMITED)
📊 Nifty50 Stock: NO
📊 Sectoral Index: NIFTY INFRASTRUCTURE / NIFTY 500 / NIFTY SMALLCAP / NIFTY METAL
📊 Sector: Capital Goods
📊 Industry: Industrial Products
Key highlights: 💡⚡
📈 Script is trading at middle band of Bollinger band (BB) and taking support of middle band which is SMA20.
📈 Already crossover in MACD .
📈 Crossover in Double Moving Averages.
📈 Right now RSI is around 60.
📈 Todays volume is higher then previous trading session so we can say it is volume Breakout.
📈 One can go for Swing Trade.
⏱️ C.M.P 📑💰- 233.70
🟢 Target 🎯🏆 - 250
⚠️ Stoploss ☠️🚫 - 223
⚠️ Important: Always maintain your Risk & Reward Ratio.
✅Like and follow to never miss a new idea!✅
Disclaimer: I am not SEBI Registered Advisor. My posts are purely for training and educational purposes.
Eat🍜 Sleep😴 TradingView📈 Repeat🔁
Happy learning with trading. Cheers!🥂
$IBO is emerging incalculably and investing its point$IBO is influencing auxiliary with fleetness on the TSX-V, as well as displaying a fantastic unit on the market, which was quite incredible!
universalibogaine inc Path Forward
Universal Ibogaine intends to acquire a network of addiction treatment clinics, licensing our treatment protocols to best in class treatment providers around the globe.
Russell 2000: historical drawdowns point to more downside riskThe Russell 2000 's drawdown from its peak has been important (-26%), but not as severe as those seen during the dot-com bubble in 2002, the 2008 financial crisis, and Covid-19 at the start of 2020, when the US small-cap index plummeted by more than 40%.
To reverse the current downtrend of the Russell 2000 , the underlying causes must also be reversed, which are primarily rising inflation and the need to raise interest rates.
US ECONOMY: MACRO OVERVIEW
Inflation is now widespread and is not solely due to increases in energy prices, such as oil and natural gas . The United States still has a very tight labour market that requires a rebalancing of supply and demand, to avoid further wage pressures. There are currently nearly two job openings for every unemployed American ( FRED:JTSJOL / FRED:UNEMPLOY ) and the labor-force participation rate has not recovered to pre-Covid levels. The result is a strong pressure on salary growth , which is currently at 11% year-on-year.
The combination of higher energy prices and wage pressures raises labour input costs for US firms. Those who are unable to pass on higher costs to their customers will see their profit margins dwindle dangerously. In addition, since the Fed is firmly committed to raising interest rates , higher borrowing costs represent an additional drag on the growth outlook of small-cap firms.
RUSSELL 2000 index: outlook
The market believes that a recession will cause the Federal Reserve to slow its rate hikes or even reverse its policy stance. However, the Fed's focus remains solely on inflation, as the labour market remains close to full employment. To rebalance the labour market, the Fed will continue to raise interest rates aggressively.
The short/medium term outlook on the Russell 2000 index remains bearish until the Fed signals a change, which is unlikely unless there is a major recession.
A 40% drop from the peak would be a good entry point for opportunistic buyers to step in, indicating a wide bullish positioning clean-up. Such a level of drawdown corresponds to a Russell 2000 index level of 1,450.
$IBO announced a vital addition of clinical trials director
Julie Dumouchel has been named Director of Clinical Trials at UI, which is a significant strategic move. Julie Dumouchel has 25 years of experience in the pharmaceutical sector, where she has worked in a variety of clinical research jobs and has a thorough grasp of the drug development process.
$DIA oozing with oodles of profit in the market, don't miss the
$DIA, an exploration stage company, engages in the exploration and acquisition of mineral properties in Canada, and is currently trading at $0.1750, with a great jump in the market. As per the charts the stock is expected to follow a bullish pattern.
$HEM declared the addition of an entirely closely-held subsidiar
Hemostemix recently declared the incorporation of PreCerv inc . (A totally closely-held subsidiary of Hemostemix). Hemostemix can grant PreCerv a world field of use licence for NCP-01 and its autologous somatic cell technology to treat central and peripheral systema nervosum diseases.